MedTrace Logo

PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness

NCT00529945 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2007-12-21

No results posted yet for this study

Summary

The primary object of this study is to demonstrate the continued safety and performance of the PFx Closure System when utilized for patients with PFOs suffering from cryptogenic stroke, transient ischemic attack, migraine or decompression illness.

Conditions

Interventions

DEVICE

PFx Closure System

Sponsors & Collaborators

  • Cierra

    lead INDUSTRY

Principal Investigators

  • Horst Sievert, MD · Cardiovascular Center Frankfurt, Germany

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Completion
2007-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00529945 on ClinicalTrials.gov